A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Aceprometazine
Esketamine
The risk or severity of hypertension can be increased when Esketamine is combined with Solriamfetol.
Aceprometazine
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Solriamfetol.
Aceprometazine
Taranabant
The risk or severity of adverse effects can be increased when Taranabant is combined with Solriamfetol.
Aceprometazine
Remdesivir
The excretion of Solriamfetol can be decreased when combined with Remdesivir.
Aceprometazine
Pralsetinib
The excretion of Solriamfetol can be decreased when combined with Pralsetinib.
Aceprometazine
Ripretinib
The excretion of Solriamfetol can be decreased when combined with Ripretinib.
Aceprometazine
Bictegravir
The excretion of Solriamfetol can be decreased when combined with Bictegravir.
Aceprometazine
Bromotheophylline
Bromotheophylline may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Aceprometazine
Epitizide
Epitizide may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Aceprometazine
Clopamide
Clopamide may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Aceprometazine
Fenquizone
Fenquizone may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Aceprometazine
Clofenamide
Clofenamide may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Aceprometazine
Clorexolone
Clorexolone may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Aceprometazine
Mebutizide
Mebutizide may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Aceprometazine
Mefruside
Mefruside may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Aceprometazine
Meticrane
Meticrane may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Aceprometazine
Spiradoline
Spiradoline may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Aceprometazine
Rolofylline
Rolofylline may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Aceprometazine
Canrenone
Canrenone may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Aceprometazine
Isosorbide
Isosorbide may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3